gmi research logo
GMI Research
See the Future Insights
GMI Research Facebook Page GMI Research Twitter Page GMI Research Linkedin Page
U.S Office +1 860 881 2270 : Europe Office +353 1 442 8820  

Global Nucleic Acid Testing Market by Product Type (Nucleic Acid test Kits {Transcription-mediated amplification (TMA), Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Whole Genome Sequencing) and Consumables}, by Indication (Infectious Diseases, Cancer, Forensic Testing and Others), by End-User (Hospitals, Pathology Laboratories, Research Institutes and Clinics) and by Geography - Opportunities & Forecast, 2018-2025

Get Free 20% Customization in this Report


Report Code : HM09A-00-0818 Published Date: August-2018 Report Format: PPT

 

Select License Type:

Need Assitance ?


A GMI Research Sales Representative
is available to help you

U.S Office +1 860 881 2270

Europe Office +353 1 442 8820


The introduction of nucleic acid testing technology has revolutionized the field of clinical molecular diagnosis and forensic science. The nucleic acid testing market is likely to grow rapidly over the forecast period, owing to, the higher growth rate of molecular diagnosis, treatment, and research activities. Moreover, increasing adoption of nucleic acid testing in chronic disease diagnosis and forensic testing is anticipated to positively impact the market during the forecast period. The global Nucleic Acid Testing market is expected to witness significant growth during the forecast period 2018–2025.

Factors, such as the rising incidence of infectious diseases and growing cancer patients worldwide, are expected to increase the demand for diagnosis over the coming years. The molecular diagnosis industry is observing soaring adoption of nucleic acid testing techniques because of its fast, reliable and accurate outcomes. In addition, well-established healthcare infrastructure and improving reimbursement policy in developed economies and growing research & development activities across the globe, especially in Asia-Pacific region are expected to aid the market growth during 2018–2025.

Further, high demand for nucleic acid testing from blood transfusion centers and blood donation centers is predicted to significantly anchor the whole blood transfusion processes, which are foreseen to reinforce the development of nucleic acid testing market worldwide.

Various notable players operating in the market include Agilent Technologies, Danaher Corporation, Abbott Laboratories Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen, and Merck KGaA, among others.

The global nucleic acid testing market has been segmented based on product type, indication, end-user and key geographies. Based on product type, the market comprises of nucleic acid test kits and consumables. Based on the indication, the market has been segmented into infectious diseases, cancer, forensic testing and others. Based on indication, the market is categorised into Infectious Diseases, Cancer, Forensic Testing and Others. The end user segment is classified into hospitals, pathology laboratories, research institutes and clinics

The research report “global nucleic acid testing market” provides in-depth analysis of the global nucleic acid testing market based on product type, indication, end-use and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for the nucleic acid testing market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.



Key questions answered in this research report:
1-    At what pace is nucleic acid testing market growing? What will be growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the nucleic acid testing market?
4-    What are the various application areas and how they are poised to grow?
 
The global nucleic acid testing market is segmented on the basis of product type, indication, end user and geography:
 
Global Nucleic Acid Testing Market by Product Type

 

·         Nucleic Acid test Kits

o    Transcription-mediated amplification (TMA)

o    Polymerase chain reaction (PCR)

o    Ligase chain reaction (LCR)

o    Whole genome sequencing

·         Consumables

Global Nucleic Acid Testing Market by Indication

·         Infectious diseases

·         Cancer

·         Forensic Testing

·         Others

Global Nucleic Acid Testing Market by End User

·         Hospitals

·         Pathology laboratories

·         Research Institutes

·         Clinics

Global Nucleic Acid Testing Market by Geography

·         North America

·         Asia-Pacific

·         Europe

·         Rest of World

 

Global Nucleic Acid Testing Market Competitive Landscape

 

·         Major Players and their Key Strategies 

·         New product launches

·         Mergers and acquisitions

·         Collaborations, partnerships, agreements and joint venture

 1. Executive Summary 


2. Introduction            
        2.1. Study Objectives        
        2.2. Market Definition        
                2.2.1. Market Covered    
                2.2.2. Geographical Coverage    
                2.2.3. Study Years & Currency    
        2.3. Market Stakeholders        
        2.4. Key Questions this Study will Answer        
        2.5. GMI Research’s Approach & Methodology   
 
3. Global Nucleic Acid Testing Market - Overview            
        3.1. Introduction         `
        3.2. Market Segmentation        
        3.3. Value Chain Analysis        
        3.4. Drivers        
        3.5. Restraints        
        3.6. Trends      
 
4. Global Nucleic Acid Testing Market Revenue Forecast till 2025     

5. Global Nucleic Acid Testing Market by Product Type Revenue Forecast till 2025            
        5.1. Nucleic Acid test Kits
                5.1.1. Transcription-mediated amplification (TMA)
                5.1.2. Polymerase chain reaction (PCR)
                5.1.3. Ligase chain reaction (LCR)
                5.1.4. Whole genome sequencing
         5.2. Consumables
 
6. Global Nucleic Acid Testing Market by Indication Revenue Forecast till 2025            
        6.1. Infectious diseases
        6.2. Cancer
        6.3. Forensic Testing
        6.4. Others
 
7. Global Nucleic Acid Testing Market by End User Revenue Forecast till 2025            
        7.1. Hospitals
        7.2. Pathology laboratories
        7.3. Research Institutes
        7.4. Clinics
 
8. Global Nucleic Acid Testing Market by Geography Revenue Forecast till 2025
 
        8.1. North America Nucleic Acid Testing Market Revenue Forecast till 2025        
                8.1.1. North America Nucleic Acid Testing Market by Product Type (Option 1: 25% customization)
                                8.1.1.1. Nucleic Acid test Kits
                                                8.1.1.1.1. Transcription-mediated amplification (TMA)
                                                8.1.1.1.2. Polymerase chain reaction (PCR)
                                                8.1.1.1.3. Ligase chain reaction (LCR)
                                                8.1.1.1.4. Whole genome sequencing
                                8.1.1.2. Consumables
                8.1.2. North America Nucleic Acid Testing Market by Indication    
                                8.1.2.1. Infectious diseases
                                8.1.2.2. Cancer
                                8.1.2.3. Forensic Testing
                                8.1.2.4. Others
 
                8.1.3. North America Nucleic Acid Testing Market by End User    
                                8.1.3.1. Hospitals
                                8.1.3.2. Pathology laboratories
                                8.1.3.3. Research Institutes
                                8.1.3.4. Clinics 
        8.2. Europe Nucleic Acid Testing Market Revenue Forecast till 2025        
                8.2.1. Europe Nucleic Acid Testing Market by Product Type (Option 2: 25% customization)
                                8.2.1.1. Nucleic Acid test Kits
                                                8.2.1.1.1. Transcription-mediated amplification (TMA)
                                                8.2.1.1.2. Polymerase chain reaction (PCR)
                                                8.2.1.1.3. Ligase chain reaction (LCR)
                                                8.2.1.1.4. Whole genome sequencing
                                8.2.1.2. Consumables
                8.2.2. Europe Nucleic Acid Testing Market by Indication    
                                8.2.2.1. Infectious diseases
                                8.2.2.2. Cancer
                                8.2.2.3. Forensic Testing
                                8.2.2.4. Others
 
                8.2.3. Europe Nucleic Acid Testing Market by End User    
                                8.2.3.1. Hospitals
                                8.2.3.2. Pathology laboratories
                                8.2.3.3. Research Institutes
                                8.2.3.4. Clinics
  
        8.3. Asia-Pacific Nucleic Acid Testing Market Revenue Forecast till 2025        
                8.3.1. Asia-Pacific Nucleic Acid Testing Market by Product Type (Option 3: 25% customization)
                                8.3.1.1. Nucleic Acid test Kits
                                                8.3.1.1.1. Transcription-mediated amplification (TMA)
                                                8.3.1.1.2. Polymerase chain reaction (PCR)
                                                8.3.1.1.3. Ligase chain reaction (LCR)
                                                8.3.1.1.4. Whole genome sequencing
                                8.3.1.2. Consumables
                8.3.2. Asia-Pacific Nucleic Acid Testing Market by Indication    
                                8.3.2.1. Infectious diseases
                                8.3.2.2. Cancer
                                8.3.2.3. Forensic Testing
                                8.3.2.4. Others
 
                8.3.3. Asia-Pacific Nucleic Acid Testing Market by End User    
                                8.3.3.1. Hospitals
                                8.3.3.2. Pathology laboratories
                                8.3.3.3. Research Institutes
                                8.3.3.4. Clinics
  
        8.4. Rest of the World Nucleic Acid Testing Market Revenue Forecast till 2025        
                8.4.1. Rest of the World Nucleic Acid Testing Market by Product Type (Option 4: 25%                                                    customization)
                                8.4.1.1. Nucleic Acid test Kits
                                                8.4.1.1.1. Transcription-mediated amplification (TMA)
                                                8.4.1.1.2. Polymerase chain reaction (PCR)
                                                8.4.1.1.3. Ligase chain reaction (LCR)
                                                8.4.1.1.4. Whole genome sequencing
                                8.4.1.2. Consumables
                8.4.2. Rest of the World Nucleic Acid Testing Market by Indication    
                                8.4.2.1. Infectious diseases
                                8.4.2.2. Cancer
                                8.4.2.3. Forensic Testing
                                8.4.2.4. Others
 
                8.4.3. Rest of the World Nucleic Acid Testing Market by End User    
                                8.4.3.1. Hospitals
                                8.4.3.2. Pathology laboratories
                                8.4.3.3. Research Institutes
                                8.4.3.4. Clinics 
 
9. Competitive Landscape            
        9.1. Industry Attractiveness
        9.2. Porter 5 Analysis
        9.3. Major players and their key strategies
        9.4. Company Share Analysis      
 
10. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your                  Choice)
        10.1. Agilent Technologies        
                          10.1.1.1. Company Overview    
                           10.1.1.2. Financials    
                           10.1.1.3. Recent Developments    
        10.2. Danaher Corporation        
                           10.2.1.1. Company Overview    
                          10.2.1.2. Financials    
                          10.2.1.3. Recent Developments    
        10.3. Abbott Laboratories, Inc.    
                          10.3.1.1. Company Overview    
                          10.3.1.2. Financials    
                          10.3.1.3. Recent Developments    
        10.4. Becton, Dickinson and Company        
                          10.4.1.1. Company Overview    
                          10.4.1.2. Financials    
                          10.4.1.3. Recent Developments    
        10.5. Bio-Rad Laboratories Inc.        
                          10.5.1.1. Company Overview    
                          10.5.1.2. Financials    
                          10.5.1.3. Recent Developments    
        10.6. F. Hoffmann-La Roche Ltd.        
                          10.6.1.1. Company Overview    
                          10.6.1.2. Financials    
                          10.6.1.3. Recent Developments    
        10.7. Illumina, Inc.        
                          10.7.1.1. Company Overview    
                          10.7.1.2. Financials    
                          10.7.1.3. Recent Developments    
        10.8. Thermo Fisher Scientific Inc.      
                          10.8.1.1. Company Overview    
                          10.8.1.2. Financials    
                          10.8.1.3. Recent Developments    
        10.9. Qiagen 
                          10.9.1.1. Company Overview    
                          10.9.1.2. Financials    
                          10.9.1.3. Recent Developments
        10.10. Merck KGaA, 
                          10.10.1.1. Company Overview    
                          10.10.1.2. Financials    
                          10.10.1.3. Recent Developments
 
11. About GMI Research